ReVIDA Recovery® Selected for Medicare Study

Johnson City, Tenn. — It was recently announced that ReVIDA Recovery® was selected for a Medicare demonstration project. The selection for the project means the ReVIDA Recovery® opioid addiction treatment model will be tested and used as part of the nationwide project.

“ReVIDA Recovery® is one of only 54 providers selected nationwide, and the only provider selected in our service area,” a spokesperson for ReVIDA Recovery® said.

The goal of this study would be to make it possible for more people in the Johnson City, Tenn., area to have access to treatment. This is a four-year plan that hopes to improve the behavioral and physical health outcomes for those on Medicare.

“We promote safe and healthy communities by empowering individuals to reclaim their lives from opioid use disorder,” a spokesperson for ReVIDA Recovery® said. “Our team of physicians, nurses, care coordinators, and counselors is committed to clinical excellence and ensuring each patient has the greatest chance at recovery.”

Founder and CEO Lee Dilworth shared his thoughts as well. “We are proud to be included in this important study and recognized for our work reclaiming lives in East Tennessee and Southwest Virginia. We look forward to seeing the impact of this study on our patients over the next four years,” Dilworth said.

ReVIDA Recovery® is based in Johnson City, Tenn. with multiple locations throughout the state of Tennessee and Virginia. They rely on a multidisciplinary team of doctors and other medical professionals to provide medication-assisted treatment (MAT) throughout the area.

The vision of ReVIDA Recovery® is to develop a premier network of outpatient recovery centers that deliver clinical excellence and industry-leading outcomes.

ReVIDA Recovery® can be reached at (423) 455-9321.